XML 86 R31.htm IDEA: XBRL DOCUMENT v3.20.1
Employee Benefit Plans (Tables)
3 Months Ended
Mar. 31, 2020
Employee Benefit and Share-based Payment Arrangement, Noncash Expense [Abstract]  
Transactions Under the Company’s Stock Option Plans
Transactions under the Company’s stock option plans for the three months ended March 31, 2020 are summarized in the following table:
 
 
Shares
 
Weighted average exercise price
 
Weighted average remaining contractual life in years
 
Aggregate intrinsic value
Outstanding at December 31, 2019
 
614,311

 
$
14.78

 
6.9
 
$
4,783,402

Options granted
 
101,000

 
20.39

 
 
 
 
Options exercised
 
(5,500
)
 
6.23

 
 
 
 
Options forfeited
 

 

 
 
 
 
Options expired
 

 

 
 
 
 
Outstanding at March 31, 2020
 
709,811

 
$
15.65

 
7.1
 
$
926,893

Exercisable at March 31, 2020
 
436,981

 
$
12.55

 
5.8
 
$
926,893

Stock Options, Valuation Assumptions
The fair values of the options granted during the three months ended March 31, 2020 and 2019 were estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:

 
For the three months ended March 31,

 
2020
 
2019
Number of options granted
 
101,000

 
55,000

Weighted average exercise price
 
$
20.39

 
$
20.61

Weighted average fair value of options
 
$
5.54

 
$
6.21

Expected life in years (1)
 
8.66

 
8.23

Expected volatility (2)
 
27.13
%
 
27.08
%
Risk-free interest rate (3)
 
1.55
%
 
2.55
%
Dividend yield (4)
 
1.61
%
 
1.36
%

(1) The expected life of the options was estimated based on historical employee behavior and represents the period of time that options granted are expected to be outstanding.
(2) The expected volatility of the Company’s stock price was based on the historical volatility over the period commensurate with the expected life of the options. 
(3) The risk-free interest rate is the U.S. Treasury rate commensurate with the expected life of the options on the date of grant.
(4) The expected dividend yield is the projected annual yield based on the grant date stock price.
Schedule of Cash Proceeds Received from Share-based Payment Awards
Upon exercise, the Company issues shares from its authorized but unissued common stock to satisfy the options. The following table presents information about options exercised during the three months ended March 31, 2020 and 2019:
 
 
For the three months ended March 31,
 
 
2020
 
2019
Number of options exercised
 
5,500

 
20,434

Total intrinsic value of options exercised
 
$
86,241

 
$
240,403

Cash received from options exercised
 
$
34,265

 
$
165,943

Tax deduction realized from options
 
$
25,264

 
$
72,325

Schedule of Stock Options, by Exercise Price Range
The following table summarizes information about stock options outstanding and exercisable at March 31, 2020:
 
 
 
Options outstanding
 
Options exercisable
Range of exercise prices
 
Options outstanding
 
Weighted average remaining contractual life (in years)
 
Weighted average exercise price
 
Options exercisable
 
Weighted average exercise price
 
$0.00 - $6.00
 
59,011

 
2.4
 
$
5.60

 
59,011

 
$
5.60

 
$6.01 - $12.00
 
190,767

 
5.0
 
8.73

 
190,767

 
8.73

 
$12.01 - $18.00
 
102,533

 
7.9
 
15.94

 
67,533

 
15.78

 
$18.01 - $24.00
 
357,500

 
8.8
 
20.91

 
119,670

 
20.26

 
Total
 
709,811

 
7.1
 
$
15.65

 
436,981

 
$
12.55

Allocation of Share-based Compensation Costs
Compensation expense related to stock options and the related income tax benefit for the three months ended March 31, 2020 and 2019 are detailed in the following table:

 
For the three months ended March 31,

 
2020
 
2019
Compensation expense
 
$
192,489

 
$
136,356

Income tax benefit
 
$
55,629

 
$
39,407

Compensation expense related to restricted stock for the three months ended March 31, 2020 and 2019 is detailed in the following table:

 
For the three months ended March 31,

 
2020
 
2019
Compensation expense
 
$
172,905

 
$
146,288

Income tax benefit
 
$
49,969

 
$
42,277

Summary of Nonvested Restricted Stock Activity
The following table summarizes nonvested restricted stock activity for the three months ended March 31, 2020:
 
 
Shares
 
Average grant date fair value
Nonvested restricted stock at December 31, 2019
 
108,740

 
$
19.18

Granted
 
15,000

 
16.63

Cancelled
 

 

Vested
 
(33,718
)
 
17.08

Nonvested restricted stock at March 31, 2020
 
90,022

 
$
19.54

Restricted Stock Grants
Restricted stock awards granted during the three months ended March 31, 2020 and 2019 were as follows:

 
For the three months ended March 31,

 
2020
 
2019
Number of shares granted
 
15,000

 
30,150

Average grant date fair value
 
$
16.63

 
$
20.65

Summary of Components of Net Periodic Pension Cost of Defined Benefit Plan Recognized
The following table summarizes the components of the net periodic pension cost of the defined benefit plan recognized during the three months ended March 31, 2020 and 2019:
 
 
For the three months ended March 31,
(In thousands)
 
2020
 
2019
Service cost
 
$
31

 
$
47

Interest cost
 
37

 
29

Amortization of prior service cost
 
21

 
21

Net periodic benefit cost
 
$
89

 
$
97

Summary Of Changes In Benefit Obligations Of Defined Benefit Plan
The following table summarizes the changes in benefit obligations of the defined benefit plan during the three months ended March 31, 2020 and 2019:
 
 
For the three months ended March 31,
(In thousands)
 
2020
 
2019
Benefit obligation, beginning of year
 
$
3,571

 
$
2,747

Service cost
 
31

 
47

Interest cost
 
37

 
29

Benefit obligation, end of period
 
$
3,639

 
$
2,823